Work

Correction: Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer

Year: 2024

Type: erratum

Abstract: In Table 2 of this article, the Geometric mean (%CV) for C trough,ss (ng/mL) under the column headed "HER2+ mCRC, N = 68" was mistakenly listed as 405 (44.9) and should have been 197 (62.5).The Table 2 should have appeared as shown below.

Source: Clinical Pharmacokinetics

DOI: 10.1007/s40262-024-01458-0

Authors: Daping Zhang, Adekemi Taylor, Jie Janet Zhao, Christopher J. Endres, Ariel Topletz-Erickson

Institutions: Pfizer (United States), Certara (United States), Immunome (United States)

Language: English

Topic: Pharmaceutical studies and practices

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,790

OpenAlex ID: W4405296794

Cites:

Cited by:

Related to: 10